The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Svechnikova E.V.

Medical Institute of Continuing Education of Rosbiotech;
Polyclinic No. 1 of Administrative Directorate of the President of the Russian Federation

Zhufina S.E.

Polyclinic №1 of the Administrative Department of the President of the Russian Federation, Moscow, Russia, 119002

Age rules

Authors:

Svechnikova E.V., Zhufina S.E.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(4): 38‑43

Read: 203 times

To cite this article:

Svechnikova EV, Zhufina SE. Age rules. Non Nocere. New Therapeutic Journal. 2025;(4):38‑43. (In Russ.)

References:

  1. Deng R, Wang X, Li R. Dermatophyte infection: from fungal pathogenicity to host immune re-sponses. Front Immunol. 2023 Nov 2;14:1285887. https://doi.org/10.3389/fimmu.2023.1285887
  2. Russian Society of Dermatovenerologists and Cosmetologists. Clinical recommendations. Mycoses of the skin of the scalp, trunk, hands and feet. Year of approval: 2022. Date of access: 05.04.2025. https://reclin.ru/artickle/mikozy-kozhi-golovy-tulovishha-kistej-i-stop/
  3. Wang R, Huang C, Zhang Y, Li R. Invasive dermatophyte infection: A systematic review. Mycoses. 2021 Apr;64(4):340-348.  https://doi.org/10.1111/myc.13212
  4. Ma Y, Wang X, Li R. Cutaneous and subcutaneous fungal infections: recent developments on host-fungus interactions. Curr Opin Microbiol. 2021 Aug;62:93-102.  https://doi.org/10.1016/j.mib.2021.05.005
  5. Gupta C, Das S, Gaurav V, et al. Review on host-pathogen interaction in dermatophyte infections. J Mycol Med. 2023 Mar;33(1):101331. https://doi.org/10.1016/j.mycmed.2022.101331
  6. Martinez-Rossi NM, Peres NTA, Bitencourt TA, Martins MP, Rossi A. State-of-the-Art Dermatophyte Infections: Epidemiology Aspects, Pathophysiology, and Resistance Mechanisms. J Fungi (Basel). 2021 Aug 3;7(8):629.  https://doi.org/10.3390/jof7080629
  7. Ogryzko E.V., Shevchenko A.G., Ivanova M.A. Dynamics of dermatophytosis morbidity in the Russian Federation for 2005-2020. Social aspects of population health [online edition]. 2023;69(3):3.  https://doi.org/10.21045/2071-5021-2023-69-3-3
  8. Verma S, Vasani R, Reszke R, Matusiak L, Szepietowski JC. The influence of superficial dermatophytoses epidemic in India on patients’ quality of life. Postepy Dermatol Alergol. 2021 Feb;38(2):102-105.  https://doi.org/10.5114/ada.2019.90088
  9. Rodríguez-Cerdeira C, Martínez-Herrera E, Szepietowski JC, et al. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):844-883.  https://doi.org/10.1111/jdv.16951
  10. Son JH, Doh JY, Han K, et al. Risk factors of dermatophytosis among Korean adults. Sci Rep. 2022 Aug 4;12(1):13444. https://doi.org/10.1038/s41598-022-17744-5
  11. Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA. Global prevalence of onychomycosis in general and special populations: An updated perspective. Mycoses. 2024 Apr;67(4): e13725. https://doi.org/10.1111/myc.13725
  12. Kokandi AA. Tinea Incognito. Clin Cosmet Investig Dermatol. 2024 May 6;17:993-998.  https://doi.org/10.2147/CCID.S465942
  13. Dhaher S. Tinea incognito: Clinical perspectives of a new imitator. Dermatol Reports. 2020 Jun 25;12(1):8323. https://doi.org/10.4081/dr.2020.8323
  14. Russo R, Trave I, Cozzani E, Parodi A. Generalized Tinea Incognito Developing from «Mask Tinea». Mycopathologia. 2023 Jun;188(3):263-266.  https://doi.org/10.1007/s11046-022-00686-x
  15. Cunningham EP, Carter NF. Tinea incognito «mask» erading as allergic contact dermatitis due to COVID-19 facial covering in children. Pediatr Dermatol. 2022 Mar;39(2):326-327.  https://doi.org/10.1111/pde.14911
  16. Dvoryankova E.V. Dermatophytosis in the elderly, children and pregnant women. Dermatology (Suppl. Consilium Medicum). 2018; 1: 9–12.  https://doi.org/10.26442/2414-3537_2018.1.9-12
  17. Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options. Indian J Dermatol Venereol Leprol. 2021 [SEASON];87(4):468-482.  https://doi.org/10.25259/IJDVL_303_20
  18. Bhatia A, Kanish B, Badyal DK, Kate P, Choudhary S. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – A prospective, randomized comparative study. Indian J Pharmacol. 2019 Mar-Apr;51(2):116-119.  https://doi.org/10.4103/ijp.IJP_578_17
  19. Westerberg DP, Voyack MJ. Onychomycosis: Current trends in diagnosis and treatment. Am Fam Physician. 2013 Dec 1;88(11): 762-770. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.